QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic DiseasesZacks Investment Research • 08/30/24
ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Certain Patients with HER2 Low or HER2 Ultralow Metastatic Breast CancerBusiness Wire • 08/19/24
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA NegotiationsInvestors Business Daily • 08/15/24
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs MarketThe Motley Fool • 08/04/24
AstraZeneca falls after UK drug watchdog blocks NHS access to Enhertu drugProactive Investors • 07/30/24
Pharma companies less concerned after hearing from US on negotiated prices for MedicareReuters • 07/29/24